News
RENEW Phase 2 trial evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) initiated with topline interim data expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback